These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8997599)

  • 21. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
    Mele A; Castellano C; Felici A; Cabib S; Caccia S; Oliverio A
    Eur J Pharmacol; 1996 Jul; 308(1):1-12. PubMed ID: 8836626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacologic evaluation of SCH-39166, A-69024, NO-0756, and SCH-23390 in neonatal-6-OHDA-lesioned rats. Further evidence that self-mutilatory behavior induced by L-dopa is related to D1 dopamine receptors.
    Criswell HE; Mueller RA; Breese GR
    Neuropsychopharmacology; 1992 Sep; 7(2):95-103. PubMed ID: 1418306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions between D1 and D2 dopamine receptor family agonists and antagonists: the effects of chronic exposure on behavior and receptor binding in rats and their clinical implications.
    Braun AR; Laruelle M; Mouradian MM
    J Neural Transm (Vienna); 1997; 104(4-5):341-62. PubMed ID: 9295170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indirect dopamine agonists effects on despair test: dissociation from hyperactivity.
    Vaugeois JM; Pouhé D; Zuccaro F; Costentin J
    Pharmacol Biochem Behav; 1996 May; 54(1):235-9. PubMed ID: 8728563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evidence for dopamine 'D1-like' receptor subtypes in the behavioural effects of two new selective antagonists, LY 270411 and BW 737C.
    Deveney AM; Waddington JL
    Eur J Pharmacol; 1996 Dec; 317(2-3):175-81. PubMed ID: 8997598
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic interaction between an adenosine antagonist and a D1 dopamine agonist on rotational behavior and striatal c-Fos induction in 6-hydroxydopamine-lesioned rats.
    Pollack AE; Fink JS
    Brain Res; 1996 Dec; 743(1-2):124-30. PubMed ID: 9017239
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dihydrexidine produces hypothermia in rats via activation of dopamine D1 receptors.
    Salmi P; Ahlenius S
    Neurosci Lett; 1997 Oct; 236(1):57-9. PubMed ID: 9404951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential ability of D1 and D2 dopamine receptor agonists to induce and modulate expression and reinstatement of cocaine place preference in rats.
    Graham DL; Hoppenot R; Hendryx A; Self DW
    Psychopharmacology (Berl); 2007 Apr; 191(3):719-30. PubMed ID: 16835769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stimulating dopamine D1 receptors increases the locomotor activity of developing rats.
    Shieh GJ; Walters DE
    Eur J Pharmacol; 1996 Sep; 311(2-3):103-7. PubMed ID: 8891588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?
    Isacson R; Kull B; Wahlestedt C; Salmi P
    Neuroscience; 2004; 124(1):33-42. PubMed ID: 14960337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sedative effects of the dopamine D1 receptor agonist A 68930 on rat open-field behavior.
    Salmi P; Ahlenius S
    Neuroreport; 2000 Apr; 11(6):1269-72. PubMed ID: 10817605
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dopamine receptor antagonists block nerve growth factor-induced hyperactivity.
    Kobayashi S; Ogren SO; Ebendal T; Olson L
    Eur J Pharmacol; 1997 May; 326(1):1-5. PubMed ID: 9178648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of uncoupling between D1- and D2-mediated motor behavior in rats depleted of dopamine as neonates.
    Byrnes EM; Bruno JP
    Dev Psychobiol; 1994 Sep; 27(6):409-24. PubMed ID: 8001729
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
    Koshikawa N; Kitamura M; Kobayashi M; Cools AR
    Eur J Pharmacol; 1996 Jul; 308(3):235-41. PubMed ID: 8858293
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of interactions of D1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents.
    Chausmer AL; Katz JL
    Psychopharmacology (Berl); 2002 Jan; 159(2):145-53. PubMed ID: 11862342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dopamine D1 receptor agonist SKF-82958 effectively increases eye blinking count in common marmosets.
    Kotani M; Kiyoshi A; Murai T; Nakako T; Matsumoto K; Matsumoto A; Ikejiri M; Ogi Y; Ikeda K
    Behav Brain Res; 2016 Mar; 300():25-30. PubMed ID: 26675887
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats.
    Criswell HE; Johnson KB; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1993 May; 265(2):1001-10. PubMed ID: 8098756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of D2 or combined D1/D2 receptor antagonism on the methamphetamine-induced one-trial and multi-trial behavioral sensitization of preweanling rats.
    Mohd-Yusof A; Veliz A; Rudberg KN; Stone MJ; Gonzalez AE; McDougall SA
    Psychopharmacology (Berl); 2016 Mar; 233(5):893-903. PubMed ID: 26650612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polydipsia and dopamine: behavioral effects of dopamine D1 and D2 receptor agonists and antagonists.
    Mittleman G; Rosner AL; Schaub CL
    J Pharmacol Exp Ther; 1994 Nov; 271(2):638-50. PubMed ID: 7965779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of intra-nucleus accumbens shell administration of dopamine agonists and antagonists on cocaine-taking and cocaine-seeking behaviors in the rat.
    Bachtell RK; Whisler K; Karanian D; Self DW
    Psychopharmacology (Berl); 2005 Nov; 183(1):41-53. PubMed ID: 16163523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.